Latest Investments News

Paladin Energy reports a 16% rise in uranium production at Langer Heinrich Mine, with strong sales and a fortified balance sheet positioning the company for growth. Exploration advances in Canada and leadership changes signal a strategic push forward.

Emerald Resources has announced a 27% increase in the Mineral Resource Estimate for its Memot Gold Project in Cambodia, now totaling 1.7 million ounces of gold, with full permitting in place to begin development this year.

OMG Group Limited has reported its first positive operating cashflow quarter, driven by a 63% year-on-year sales increase and expansion into premium Japanese matcha wholesale. This milestone signals a turning point in the company’s growth trajectory.

Westgold Resources has reported a record-breaking second quarter for FY26, with gold production surging 33% and underlying cash build doubling to $365 million, while maintaining a debt-free balance sheet.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

Green & Gold Minerals reports outstanding high-grade gold drill results from Mt Wandoo and Little Wandoo, accelerating its development plans and expanding resource potential.

Energy Fuels Inc. has announced a proposed acquisition of Australian Strategic Materials (ASM) valued at approximately A$447 million, aiming to establish a leading Western rare earths and critical minerals producer with a fully integrated supply chain.

Energy Fuels Inc. has announced a binding agreement to acquire Australian Strategic Materials Ltd (ASM) in a deal valuing ASM at approximately A$447 million, offering shareholders a 121% premium. The acquisition aims to establish a vertically integrated Western rare earths supply chain, aligning with critical minerals strategies between the US and Australia.

Tivan Limited has made significant strides in its critical minerals portfolio, securing a $51.3 million strategic investment and progressing key feasibility studies across multiple projects.

BCAL Diagnostics has launched its Avantect pancreatic and ovarian cancer tests in Australia, alongside expanding clinical data and establishing a national registry for its BREASTESTplus breast cancer test.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

Astral Resources reports strong high-grade gold assay results from recent drilling at its Feysville and Mandilla projects in Western Australia, highlighting significant extensions beyond current resource models and advancing development prospects.